Vaccination against helminth parasites - The ultimate challenge for vaccinologists?

Immunological Reviews

Volumn 171, Issue , 1999, Pages 125-147

  Maizels, Rick M ^a   Holland, Martin J ^a   Falcone, Franco H ^a   Zang, Xing Xing ^a   Yazdanbakhsh, Maria ^b  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; CYTOKINE; PARASITE ANTIGEN; PROTEIN; VACCINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; DRUG DELIVERY SYSTEM; GENETIC CONSERVATION; HELMINTH; HELMINTHIASIS; HUMAN; IMMUNE SYSTEM; IMMUNOPATHOGENESIS; MAMMAL; NONHUMAN; PRIORITY JOURNAL; REVIEW; RODENT; T LYMPHOCYTE; VACCINATION;

ANIMALS; ANTIGEN-ANTIBODY REACTIONS; CYTOKINES; HELMINTHIASIS; HELMINTHS; HUMANS; IMMUNITY, CELLULAR; VACCINATION;

EID: 0032719191     PISSN: 01052896     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-065X.1999.tb01345.x     Document Type: Review

References (236)

1. 1. Crompton DWT. The prevalence of ascariasis. Parasitol Today 1988;4:162-169.
2. 2. Allen JE, Maizels RM. Immunology of human helminth infection. Int Arch Allergy Immunol 1996;109:3-10.
3. 3. Allen JE, Maizels RM. Th1-Th2: reliable paradigm or dangerous dogma? Immunol Today 1997;18:387-392.
4. 4. Urban JF, et al. The importance of Th2 cytokines in protective immunity to nematodes. Immunol Rev 1992;127:205-220.
5. 5. Sher AF, Coffman RL. Regulation of immunity to parasites by T cells and T cell-derived cytokines. Annu Rev Immunol 1992;10:385-409.
6. 6. Maizels RM, Bundy DAP, Selkirk ME, Smith DF, Anderson RM. Immunological modulation and evasion by helminth parasites in human populations. Nature 1993;365:797-805.
7. 7. Locksley RM. Th2 cells: help for helminths. J Exp Med 1994;179:1405-1407.
8. 8. Abbas AK, Murphy KM, Sher A. Functional diversity of helper T lymphocytes. Nature 1996;383:787-793.
9. 9. Del Prete G, et al. Purified protein derivative of Mycobacterium tuberculosis and excretory-secretory antigen(s) of Toxocara canis expand human T cells with stable and opposite (type 1 T helper or type 2 T helper) profile of cytokine production. J Clin Invest 1991;88:346-350.
10. 10. Mahanty S, et al. IL-4-and IL-5-secreting lymphocyte populations are preferentially stimulated by parasite derived antigens in human tissue invasive nematode infections. J Immunol 1993;151:3704-3711.
11. 11. Maizels RM, Sartono E, Kurniawan A, Selkirk ME, Partono F, Yazdanbakhsh M. T cell activation and the balance of antibody isotypes in human filariasis. Parasitol Today 1995;11:50-56.
12. 12. Dimock KA, Eberhard ML, Lammie PJ. Th1-like antifilarial immune responses predominate in antigen-negative persons. Infect Immun 1996;64:2962-2967.
13. 13. De Boer B, Fillié YE, Kruize YCM, Yazdanbakhsh M. Antigen-stimulated IL-4, IL-13 and IFN-γ production by human T cells at a single cell level. Eur J Immunol 1998;28:3154-3160.
14. 14. Sartono E, Kruize YCM, Kurniawan A, Maizels RM, Yazdanbakhsh M. In Th2 biased lymphatic filarial patients, responses to PPD remain Th1. Eur J Immunol 1996;26:501-504.
15. 15. Kullberg MC, Pearce EJ, Hieny SE, Sher A, Berzofsky JA. Infection with Schistosoma mansoni alters Th1/Th2 cytokine responses to a non-parasite antigen. J Immunol 1992;148:3264-3270.
16. 16. Brunet LR, Dunne DW, Pearce EJ. Cytokine interaction and immune responses during Schistosoma mansoni infection. Parasitol Today 1998;14:422-427.
17. 17. Doenhoff MJ, et al. Immunological control of hepatotoxicity and parasite egg excretion in Schistosoma mansoni infections: stage specificity of the reactivity of immune serum in T-cell deprived mice. Trans R Soc Trop Med Hyg 1981;75:41-53.
18. 18. Amiri P, et al. Tumour necrosis factor α restores granulomas and induces parasite egg-laying in schistosome-infected SCID mice. Nature 1992;356:604-607.
19. 19. Chiaramonte MG, Schopf LR, Neben TY, Cheever AW, Donaldson DD, Wynn TA. IL-13 is a key regulatory cytokine for Th2 cell-mediated pulmonary granuloma formation and IgE responses induced by Schistosoma mansoni eggs. J Immunol 1999;162:920-930.
20. 20. Stadecker MJ. The shrinking schistosomal egg granuloma: how accessory cells control T cell-mediated pathology. Exp Parasitol 1994;79:198-201.
21. 21. Stadecker MJ, Flores Villanueva PO. Accessory cell signals regulate Th-cell responses: from basic immunology to a model for helminthic disease. Immunol Today 1994;15:571-574.
22. 22. Goerdt S, Orfanos CE. Other functions, other genes: alternative activation of antigen-presenting cells. Immunity 1999;10:137-142.
23. 23. Brunet LR, Finkelman FD, Cheever AW, Kopf MA, Pearce EJ. IL-4 protects against TNF-α-mediated cachexia and death during acute schistosomiasis. J Immunol 1997;159:777-785.
24. 24. Behnke JM, Barnard CJ, Wakelin D. Understanding chronic nematode infections: evolutionary considerations, current hypotheses and the way forward. Int J Parasitol 1992;22:861-907.
25. 25. King CL, et al. Cytokine control of parasite-specific anergy in human lymphatic filariasis. Preferential induction of a regulatory T helper type 2 lymphocyte subset. J Clin Invest 1993;92:1667-1673.
26. 26. Yazdanbakhsh M, et al. T cell responsiveness correlates differentially with antibody isotype levels in clinical and asymptomatic filariasis. J Infect Dis 1993;167:925-931.
27. 27. Colley DG, et al. Immune responses during human schistosomiasis. XII. Differential responsiveness in patients with hepatosplenic disease. Am J Trop Med Hyg 1986;35:793-802.
28. + cells after chemotherapy in human Schistosoma haematobium infection. Eur J Immunol 1996;26:1365-1370.
29. 29. King CL, et al. Cytokine control of parasite-specific anergy in human urinary schistosomiasis. IL-10 modulates lymphocyte reactivity. J Immunol 1996;156:4715-4721.
30. 30. Greene BM, Fanning MM, Ellner JJ. Non-specific suppression of antigen-induced lymphocyte blastogenesis in Onchocerca volvulus infection in man. Clin Exp Immunol 1983;52:259-265.
31. 31. Sartono E, Kruize YCM, Kurniawan-Atmadja A, Maizels RM, Yazdanbakhsh M. Depression of antigen-specific interleukin-5 and interferon-γ responses in human lymphatic filariasis as a function of clinical status and age. J Infect Dis 1997;175:1276-1280.
32. 32. Yazdanbakhsh M. Common features of T cell reactivity in persistent helminth infections: lymphatic filariasis and schistosomiasis. Immunol Lett (In press).
33. 33. Maizels RM, Lawrence RA. Immunological tolerance: the key feature in human filariasis? Parasitol Today 1991;7:271-176.
34. 34. Ottesen EA. Infection and disease in lymphatic filariasis: an immunological perspective. Parasitology 1992;104:S71-S79.
35. 35. Sartono E, et al. Elevated cellular responses and interferon-γ release after long-term diethylcarbarnazine treatment of patients with human lymphatic filariasis. J Infect Dis 1995;171:1683-1687.
36. 36. Mahanty S, et al. High levels of spontaneous and parasite antigen-driven interleukin-10 production are associated with antigen-specific hyporesponsiveness in human lymphatic filariasis. J Infect Dis 1996;173:769-773.
37. 37. Dimock KA, Addiss DG, Eberhard ML, Lammie PJ. Differential proliferative and interleukin-10 responses to fractionated filarial antigens: preferential recognition by patients with chronic lymphatic dysfunction. J Infect Dis 1994;170:403-412.
38. 38. Sartono E, Kruize YCM, Partono F, Kurniawan A, Maizels RM, Yazdanbakhsh M. Specific T cell unresponsiveness in human filariasis: diversity in underlying mechanisms. Parasite Immunol 1995;17:587-594.
39. 39. Grogan JL, Kremsner PG, Deelder AM, Yazdanbakhsh M. The effect of anti-IL-10 on proliferation and cytokine production in human schistosomiasis: fresh versus cryopreserved cells. Parasite Immunol 1998;20:345-349.
40. + T cells upon acute versus persistent viral infection. Immunity 1998;9:449-457.
41. 41. Chen Y, Kuchroo VK, Inobe J-I, Hafler DA, Weiner HL. Regulatory T cell clones induced by oral tolerance: suppression of autoimmune encephalomyelitis. Science 1994;265:1237-1240.
42. + T-cell subset inhibits antigen specific T-cell responses and prevents colitis. Nature 1997;389:737-742.
43. 43. MacDonald TT, et al. Histopathology and immunohistochemistry of the caecum in children with Trichuris dysentery syndrome. J Clin Pathol 1991;44:194-199.
44. 44. Ploegh HL. Viral strategies of immune evasion. Science 1998;280:248-253.
45. 45. Molinari M, et al. Selective inhibition of Ti-dependent antigen presentation by Helicobacter pylori toxin VacA. J Exp Med 1998;187:135-140.
46. 46. Harnett W, Harnett MM. Inhibition of murine B cell proliferation and down-regulation of protein kinase C levels by a phosphorylcholine-containing filarial excretory-secretory product. J Immunol 1993;151:4829-4837.
47. 47. Auriault C, Ouaissi MA, Torpier G, Eisen H, Capron A. Proteolytic cleavage of IgG bound to the Fc receptor of Schistosoma mansoni schistosomula. Parasite Immunol 1981;3:33-41.
48. 48. Ou X, Tang L, McCrossan M, Henkle-Dührsen K, Selkirk ME. Brugia malayi: localisation and differential expression of extracellular and cytoplasmic CuZn superoxide dismutases in adults and microfilariae. Exp Parasitol 1995;80:515-529.
49. 49. Zang XX, Yazdanbakhsh M, Kiang H, Kanost MR, Maizels RM. A novel serpin expressed by the blood-borne microfilariae of the parasitic nematode Brugia malayi inhibits human neutrophil serine proteinases. Blood (In press).
50. 50. Allen JE, Lawrence RA, Maizels RM. Antigen presenting cells from mice harboring the filarial nematode, Brugia malayi, prevent cellular proliferaton but not cytokine production. Int Immunol 1996;8:143-151.
51. 51. MacDonald AS, Maizels RM, Lawrence RA, Dransfield I, Allen JE. Requirement for in vivo production of IL-4, but not IL-10, in the induction of proliferative suppression by filarial parasites. J Immunol 1998;160:1304-1312.
52. 52. Wilson RA, Coulson PS. Lung-phase immunity to schistosomes: a new perspective to an old problem. Parasitol Today 1989;5:274-278.
53. 53. Butterworth AE, Sturrock RF, Houba V, Mahmoud AA, Sher A, Rees PH. Eosinophils as mediators of antibody-dependent damage to schistosomula. Nature 1975;256:727-729.
54. 54. Capron A, Dessaint JP, Capron M, Ouma JH, Butterworth AE. Immunity to schistosomes: progress toward vaccine. Science 1987;238:1065-1072.
55. 55. James SL. Induction of protective immunity against Schistosoma mansoni by a nonliving vaccine. III. Correlation of resistance with induction of activated larvicidal macrophages. J Immunol 1986;136:3872-3877.
56. 56. Lange AM, Yutanawiboonchai W, Lok JB, Trpis M, Abraham D. Induction of protective immunity against larval Onchocerca volvulus in a mouse model. Am J Trop Med Hyg 1993;49:783-788.
57. 57. Taylor MJ, van Es RP, Shay K, Townson S, Bianco AE. Acanthocheilonema viteae: reduction in the expression of protective immunity against infective larvae in the jird as assessed by micropore chamber vs systemic challenge infections. Exp Parasitol 1995;80:560-562.
58. 58. Lloyd S, Soulsby EJL. The role of IgA immunoglobulins in the passive transfer of protection to Taenia taenideformis in the mouse. Immunology 1978;34:939-945.
59. 59. Mangold BL, Dean DA. Passive transfer with serum and IgG antibodies of irradiated cercaria-induced resistance against Schistosoma mansoni in mice. J Immunol 1986;136:2644-2648.
60. 60. Medeiros F, Baldwin CI, Denham DA. Brugia pahangi in cats: the passive transfer of anti-microfilarial immunity from immune to non-immune cats. Parasite Immunol 1996;18:79-86.
61. 61. Ahmad A, Wang CH, Bell RG. A role for IgE in intestinal immunity. Expression of rapid expulsion of Trichinella spiralis in rats transfused with IgE and thoracic duct lymphocytes. J Immunol 1992;146:3563-3570.
62. 62. Baldwin CI, de Medeiros F, Denham DA. IgE responses in cats infected with Brugia pahangi. Parasite Immunol 1993;15:291-296.
63. 63. Nyindo M, et al. Role of adult worm antigen-specific immunoglobulin E in acquired immunity to Schistosoma mansoni infection in baboons. Infect Immun 1999;67:636-642.
64. 64. King CL, Xianli J, Malhotra I, Liu S, Mahmoud AAF, Oettgen HC. Mice with a targeted deletion of the IgE gene have increased worm burdens and reduced granulomatous inflammation following primary infection with Schistosoma mansoni. J Immunol 1997;158:294-300.
65. 65. Amiri P, Haak-Frendscho M, Robbins K, McKerrow JH, Stewart T, Jardieu P. Anti-immunoglobulin E treatment decreases worm burden and egg production in Schistosoma mansoni-infected normal and interferon-γ knockout mice. J Exp Med 1994;180:43-51.
66. 66. El Ridi R, Ozaki T, Kamiya H. Schistosoma mansoni infection in IgE-producing and IgE-deficient mice. J Parasitol 1998;84:171-174.
67. 67. Jankovic D, et al. FceRI deficient mice infected with Schistosoma mansoni mount normal Th2-type responses while displaying enhanced liver pathology. J Immunol 1997;159:1868-1875.
68. 68. Maizels RM, Holland M. Parasite immunity: pathways for expelling intestinal parasites. Curr Biol 1998;8: R711-R714.
69. 69. Finkelman FD, et al. Cytokine regulation of host defense against parasitic gastrointestinal nematodes: lessons from studies with rodent models. Annu Rev Immunol 1997;15:505-533.
70. 70. Urban JF Jr, Maliszewski CR, Madden KB, Katona IM, Finkelman FD. IL-4 treatment can cure established gastrointestinal nematode infections in immunocompetent and immunodeficient mice. J Immunol 1995;154:4675-4684.
71. 71. Barner M, Welte M, Brombacher F, Kopf M. Differences between IL-4Rα and IL4-deficient mice reveal a novel role of IL-13 in the regulation of Th2 responses. Curr Biol 1998;8:669-672.
72. 72. Urban JF Jr, et al. IL-13, IL-4Rα and Stat6 are required for the expulsion of the gastrointestinal nematode parasite Nippostrongylus brasiliensis. Immunity 1998;8:255-264.
73. 73. Bancroft AJ, McKenzie ANJ, Grencis RK. A critical role for IL-13 in resistance to intestinal nematode infection. J Immunol 1998;160:3453-3461.
74. 74. Else KJ, Finkelman FD, Maliszewski CR, Grencis RK. Cytokine-mediated regulation of chronic intestinal helminth infection. J Exp Med 1994;179:347-351.
75. 75. Bancroft AJ, Else KJ, Sypek JP, Grencis RK. Interleukin-12 promotes a chronic intestinal nematode infection. Eur J Immunol 1997;27:866-870.
76. 76. Nawa Y, et al. Selective effector mechanisms for the expulsion of intestinal helminths. Parasite Immunol 1994;16:333-338.
77. 77. McKenzie GJ, Bancroft A, Grencis RK, McKenzie ANJ. Central role for interleukin-13 in Th2 cell mediated immune responses. Curr Biol 1998;8:339-342.
78. 78. Vallance BA, Collins SM. The effect of nematode infection upon intestinal smooth muscle function. Parasite Immunol 1998;20:249-253.
79. 79. Selkirk ME, Maizels RM, Yazdanbakhsh M. Immunity and the prospects for vaccination against filariasis. Immunobiology 1992;184:263-281.
80. 80. Lawrence RA, Allen JE, Gregory WF, Kopf M, Maizels RM. Infection of IL 4 deficient mice with the parasitic nematode Brugia malayi demonstrates that host resistance is not dependent on a Th2 dominated immune response. J Immunol 1995;154:5995-6001.
81. 81. Maréchal P, et al. Immune response to the filaria Litomosoides sigmodontis in susceptible and resistant mite. Parasite Immunol 1997;19:273-279.
82. 82. Wynn TA, et al. IL-12 enhances vaccine-induced immunity to schistosomes by augmenting both humoral and cell mediated immune responses against the parasite. J Immunol 1996;157:4068-4078.
83. 83. Anderson S, Shires VL, Wilson RA, Mountford AP. In the absence of IL-12, the induction of Th1-mediated protective immunity by the attenuated schistosome vaccine is impaired, revealing an alternative pathway with Th2-type characteristics. Eur J Immunol 1998;28:2827-2838.
84. 84. Caulada-Benedetti Z, Al-Zamel F, Sher A, James S. Comparison of Th1-and Th2-associated immune reactivities stimulated by single versus multiple vaccination of mice with irradiated Schistosoma mansoni cercariae. J Immunol 1991;146:1655-1660.
85. 85. Emery I, Leclerc C, Sengphommachanh K, Vuitton DA, Liance M. In vivo treatment with recombinant IL-12 protects C57BL/6J mice against secondary alveolar echinococcosis. Parasite Immunol 1998;20:81-91.
86. 86. Terrazas LI, Bojalil R, Govezensky T, Larralde C. Shift from an early protective Th1-type immune response to a late permissive Th2-type response in murine cysticercosis (Taenia crassiceps). J Parasitol 1998;84:74-81.
87. + cells at the site of antigen deposition predicts the development if a T helper cell response to Schistosoma mansoni eggs. J Immunol 1995;155:4844-4853.
88. 88. Abe T, Sugaya H, Ishida K, Khan WI, Tasdemir I, Yoshimura K. Intestinal protection against Strongyloides ratti and mastocytosis induced by administration of interleukin-3 in mice. Immunology 1993;80:116-121.
89. 89. Lantz CS, et al. Role for interleukin-3 in mast-cell and basophil development and in immunity to parasites. Nature 1998;392:90-93.
90. 90. Faulkner H, Humphreys N, Renauld J-C, Van Snick J, Grencis RK. Interleukin-9 is involved in host protective immunity to intestinal nematode infection. Eur J Immunol 1997;27:2536-2540.
91. 91. Brown TR. Studies on trichinosis, with especial reference to the increase of the eosinophilic cells in the blood and the muscle, the origin of these cells and their diagnostic importance. J Exp Med 1898;3:315-347.
92. 92. Sasaki O, Sugaya H, Ishida K, Yoshimura K. Ablation of eosinophils with anti-IL-5 antibody enhances the survival of intracranial worms of Angiostrongylus cantonensis in the mouse. Parasite Immunol 1993;15:349-354.
93. 93. Folkard SG, Hogarth PJ, Taylor MJ, Bianco AE. Eosinophils are the major effector cells of immunity to microfilariae in a mouse model of onchocerciasis. Parasitology 1996;112:323-329.
94. 94. Korenaga M, Hitoshi Y, Yamaguchi N, Sato Y, Takatsu K, Tada I. The role of interleukin-5 in protective immunity to Strongyloides venezuelensis infection in mice. Immunology 1991;72:502-507.
95. 95. Sher A, Coffman RL, Hieny S, Cheever AW. Ablation of eosinophil and IgE responses with anti-IL-5 or anti-IL-4 antibodies fails to affect immunity against Schistosoma mansoni in the mouse. J Immunol 1990;145:3911-3916.
96. 96. Shin E-H, Osada Y, Chai J-Y, Matsumoto N, Takatsu K, Kojima S. Protective roles of eosinophils in Nippostrongylus brasiliensis infection. Int Arch Allerg Appl Immunol 1997;114 (Suppl 1):45-50.
97. 97. Dent LA, et al. Interleukin-5 transgenic mice show enhanced resistance to primary infections with Nippostrongylus brasiliensis but not primary infections with Toxocara canis. Infect Immun 1999;67:989-993.
98. 98. Hagan P, Ndhlovu PD, Dunne D, Schistosome immunology, more questions than answers. Parasitol Today 1998;14:407-412.
99. 99. Stelma FF, et al. Epidemiology of Schistosoma mansoni infection in a recently exposed community in northern Senegal. Am J Trop Med Hyg 1993;49:701-706.
100. 100. Ouma JH, et al. The development of schistosomiasis mansoni in an immunologically naive immigrant population in Masongaleni, Kenya. Parasitology 1998;117:123-132.
101. 101. Fulford AJC, Webster M, Ouma JH, Kimani G, Dunne DW. Puberty and age-related changes in susceptibility to schistosome infection. Parasitol Today 1998;14:23-26.
102. 102. Wilson RA, Coulson PS. Why don't we have a schistosomiasis vaccine? Parasitol Today 1998;14:97-99.
103. 103. Hagan P, Wilkins HA, Blumenthal UJ, Hayes RJ, Greenwood BM. Eosinophilia and resistance to Schistosoma haematobium in man. Parasite Immunol 1985;7:625-632.
104. 104. Hagan P, Blumenthal UJ, Dunn D, Simpson AJG, Wilkins HA. Human IgE, IgG4 and resistance to reinfection with Schistosoma haematobium. Nature 1991;349:243-245.
105. 105. Rihet P, Demeure CE, Bourgois A, Prata A, Dessein AJ. Evidence for an association between human resistance to Schistosoma mansoni and high anti-larval IgE levels. Eur J Immunol 1991;27:2679-2686.
106. 106. Dunne DW, et al. Immunity after treatment of human schistosomiasis: association between IgE antibodies to adult worm antigens and resistance to reinfection. Eur J Immunol 1992;22:1483-1494.
107. 107. Grogan JL, et al. Antischistosome IgG4 and IgE responses are affected differentially by chemotherapy in children versus adults. J Infect Dis 1996;173:1242-1247.
108. 108. Zhang Z, et al. Association between IgE antibody against soluble egg antigen and resistance to reinfection with Schistosoma japonicum. Trans R Soc Trop Med Hyg 1997;91:606-608.
109. 109. Pritchard DI, Quinnell RJ, Walsh EA. Immunity in humans to Necator americanus: IgE, parasite weight and fecundity. Parasite Immunol 1995;17:71-75.
110. 110. Roberts M, et al. Immunity after treatment of human schistosomiasis: association between cellular responses and resistance to infection. Infect Immun 1993;61:4984.
111. 111. Medhat A, et al. Increased interleukin-4 and interleukin-5 production in response to Schistosoma haematobium adult worm antigens correlates with lack of reinfection after treatment. J Infect Dis 1998;178:512-519.
112. 112. Grogan JL, Kremsner PG, Deelder AM, Yazdanbakhsh M. Antigen specific proliferation and interferon-γ and interleukin-5 production are down-regulated during Schistosoma haematobium infection. J Infect Dis 1998;177:1433-1437.
113. 113. Elson LH, et al. Immunity to onchocerciasis: putative immune persons produce a Th1-like response to Onchocerca volvulus. J Infect Dis 1995;171:652-658.
114. 114. Mwatha JK, et al. High levels of TNF, soluble TNF receptors, soluble ICAM-1, and IFN-γ, but low levels of IL-5, are associated with hepatosplenic disease in human schistosomiasis mansoni. J Immunol 1998;160:1992-1999.
115. 115. Karanja DM, Colley DG, Nahlen BL, Ouma JH, Secor WE. Studies on schistosomiasis in western Kenya: I. Evidence for immune-facilitated excretion of schistosome eggs from patients with Schistosoma mansoni and human immunodeficiency virus coinfections. Am J Trop Med Hyg 1997;56:515-521.
116. 116. Karanja DM, et al. Studies on schistosomiasis in western Kenya: II. Efficacy of praziquantel for treatment of schistosomiasis in persons coinfected with human immunodeficiency virus-1. Am J Trop Med Hyg 1998;59:307-311.
117. 117. Mitchell GF, Garcia EG, Rivera PT, Tiu WU, Davern KM. Evidence for and implications of anti embryonation immunity in schistosomiasis. Exp Parasitol 1994;79:546-549.
118. 118. Abel L, Demenais F, Prata A, Souza AE, Dessein A. Evidence for the segregation of a major gene in human susceptibility/resistance to infection by Schistosoma mansoni. Am J Hum Genet 1991;48:959-970.
119. 119. Marquet S, et al. Genetic localization of a locus controlling the intensity of infection by Schistosoma mansoni on chromosome 5q31-q33. Nat Genet 1996;14:181-184.
120. 120. Müller-Myhsok B, et al. Further evidence suggesting the presence of a locus, on human chromosome 5q31-q33, influencing the intensity of infection with Schistosoma mansoni. Am J Hum Genet 1997;61:452-454.
121. 121. Garcia A, et al. Linkage analysis of blood Plasmodium falciparum levels: interest of the 5q31-q33 chromosome region. Am J Trop Med Hyg 1998;58:705-709.
122. 122. Rihet P, Traore Y, Abel L, Aucan C, Traoreleroux T, Fumoux F. Malaria in humans: Plasmodium falciparum blood infection levels are linked to chromosome 5q31-q33. Am J Hum Genet 1998;63:498-505.
123. 123. Waine GJ, Ross AG, Williams GM, Sleigh AC, McManus DP. HLA class II antigens are associated with resistance or susceptibility to hepatosplenic disease in a Chinese population infected with Schistosoma japonicum. Int J Parasitol 1998;28:537-542.
124. 124. Meyer CG, et al. HLA-D alleles associated with generalized disease, localized disease, and putative immunity in Onchocerca volvulus infection. Proc Natl Acad Sci USA 1994;91:7515-7519.
125. 125. Murdoch ME, et al. HLA-DQ alleles associate with cutaneous features of onchocerciasis. Hum Immunol 1997;55:46-52.
126. 126. Chan SH, et al. HLA and filariasis in Sri Lankans and Indians. Southeast Asian J Trop Med Public Health 1984;15:281-286.
127. 127. Yazdanbakhsh M, et al. HLA and elephantiasis in lymphatic filariasis. Hum Immunol 1995;44:58-61.
128. 128. Munn EA. Rational design of nematode vaccines: hidden antigens. Int J Parasitol 1997;27:359-366.
129. 129. Dunne DW. Schistosome carbohydrates. Parasitol Today 1990;6:45-48.
130. 130. Goudot-Crozel V, Caillol D, Djabali M, Dossein AJ. The major parasite surface antigen associated with human resistance to schistosomiasis is a 37 kD glyceraldehyde 3P-dehydrogenase. J Exp Med 1989;170:2065-2080.
131. 131. El Ridi R, et al. T and B cell reactivity to a 42-kDa protein is associated with human resistance to both schistosomiasis mansoni and haematobium. J Infect Dis 1998;177:1364-1372.
132. 132. Shoemaker C, Gross A, Gebremichael A, Harn D. cDNA cloning and functional expression of the Schistosoma mansoni protective antigen triose phosphate isomerase. Proc Natl Acad Sci USA 1992;89:1842-1846.
133. 133. Dunne DW, et al. The isolation of a 22 kDa band after SDS PAGE of Schistosoma mansoni adult worms and its use to demonstrate that IgE responses against the antigen(s) it contains are associated with human resistance to infection. Parasite Immunol 1997;19:79-89.
134. 134. Webster M, et al. Human immunoglobulin E responses to a recombinant 22.6 kilodalton antigen from Schistosoma mansoni adult worms are associated with low intensities of reinfection after treatment. Infect Immun 1996;64:4042-4046.
135. 135. Hafalla JCR, Alamares JG, II, Acosta LP, Dunne DW, Ramirez BL, Santiago ML. Molecular identification of a 21.7 kDa Schistosoma japonicum antigen as a target of the human IgE response. Mol Biochem Parasitol 1999;98:157-161.
136. 136. Santiago ML, et al. Identification of the Schistosoma japonicum 22.6-kDa antigen as a major target of the human IgE response: similarity of IgE-binding epitopes to allergen peptides. Int Arch Allerg Immunol 1998;117:94-104.
137. 137. Francis P, Bickle Q. Cloning of a 21.7-kDa vaccine-dominant antigen gene of Schistosoma mansoni reveals an ED hand-like motif. Mol Biochem Parasitol 1992;50:215-224.
138. 138. Freedman DO, Nutman TB, Ottesen EA. Protective immunity in Bancroftian filariasis. Selective recognition of a 43-kD larval stage antigen by infection-free individuals in an endemic area. J Clin Invest 1989;83:14-22.
139. 139. Raghavan N, Freedman N, Freedman DO, Fitzgerald PC, Ottesen EA, Nutman TB. Cloning and characterization of a potentially protective chitinase-like recombinant antigen from Wuchereria bancrofti. Infect Immun 1994;62:1901-1908.
140. 140. Bandi C, Anderson TJC, Genchi C, Blaxter ML. Phylogeny of Wolbachia-like bacteria in filarial nematodes. Proc R Soc Lond B Biol Sci 1998;265:2407-2413.
141. 141. Lloyd S. Progress in immunization against parasitic helminths. Parasitology 1981;83:225-242.
142. 142. Maizels RM, Selkirk ME. Immunobiology of nematode antigens. In: Englund PT, Sher A, eds. The biology of parasitism. New York: Alan R. Liss Inc.; 1988. p. 285-308.
143. 143. Lightowlers MW, Rickard MD. Excretory-secretory products of helminth parasites: effects on host immune responses. Parasitology 1988;96: S123-S166.
144. 144. Campbell CH. The antigenic role of the excretions and secretions of Trichinella spiralis in the production of immunity in mice. J Parasitol 1955;41:483-491.
145. 145. Jarrett WFH, Jennings FW, McIntyre WTM, Mulligan W, Urquhart GM. Irradiated helminth larvae in vaccination. Proc R Soc Med 1958;51:743-744.
146. 146. Miller TA. Vaccination against the canine hookworm diseases. Adv Parasitol 1971;9:153-183.
147. 147. Klei TR. Development of vaccines against equine helminths. Parasitol Today 1986;2:80-81.
148. 148. Richter D, Harn DA, Matuschka F-R. The irradiated cercariae vaccine model: looking on the bright side of radiation. Parasitol Today 1995;11:288-293.
149. 149. Coulson PS. The radiation attenuated vaccine against schistosomes in animal models: paradigm for a human vaccine. Adv Parasitol 1997;39:271-336.
150. 150. James SL, Pearce EJ, Sher A. Induction of protective immunity against Schistosoma mansoni by a non-living vaccine. I. Partial characterization of antigens recognized by antibodies from mice immunized with soluble schistosome extracts. J Immunol 1985;164:3432-3438.
151. 151. Mountford AP, Pearlman E. Interleukin-12 and the host response to parasitic helminths; the paradoxical effect on protective immunity and immunopathology. Parasite Immunol 1998;20:509-517.
152. 152. Wilson RA, Coulson PS, Betts C, Dowling MA, Smythies LE. Impaired immunity and altered pulmonary responses in mice with a disrupted interferon-γreceptor gene exposed to the irradiated Schistosoma mansoni vaccine. Immunology 1996;87:275-282.
153. 153. King CL, Malhotra I, Jia X. Schistosoma mansoni: protective immunity in IL 4-deficient mice. Exp Parasitol 1996;84:245-252.
154. 154. Pearce EJ, et al. Immunochemical characterization and purification of Sm-97, a Schistosoma mansoni antigen monospecifically recognized by antibodies from mice protectively immunized with a nonliving vaccine. J Immunol 1986;137:3593-3600.
155. 155. Taylor JB, et al. The glutathione transferase activity and tissue distribution of a cloned M, 28K protective antigen of Schistosoma mansoni. EMBO J 1988;7:465-472.
156. 156. Soisson LMA, Masterson CP, Tom TD, McNally MT, Lowell GH, Strand M. Induction of protective immunity in mice using a 62-kDa recombinant fragment of a Schistosoma mansoni surface antigen. J Immunol 1992;149:3612-3620.
157. 157. Reynolds SR, Shoemaker CB, Harn DA, T and B cell epitope mapping of SM23, an integral membrane protein of Schistosoma mansoni. J Immunol 1992;149:3995-4001.
158. 158. Tendler M, et al. A Schistosoma mansoni fatty acid-binding protein, Sm14, is the potential basis of a dual purpose anti-helminth vaccine. Proc Natl Acad Sci USA 1996;93:269-273.
159. 159. Bergquist NR, Colley DG. Schistosomiasis vaccines: research to development. Parasitol Today 1998;14:99-104.
160. 160. Doenhoff MJ. A vaccine for schistosomiasis: alternative approaches. Parasitol Today 1998;14:105-109.
161. 161. Jankovic D, et al. Calpain is the target antigen of a Th1 clone that transfers protective immunity against Schistosoma mansoni. J Immunol 1996;157:806-814.
162. 162. Couissinier-Paris P, et al. Identification of a major T cell immunogen in the anti-schistosome response of adult residents in an area endemic for Schistosoma mansoni. Eur J Immunol 1995;25:903-910.
163. 163. Kohlstädt S, et al. Characterization of a schistosome T cell-stimulating antigen (Sm10) associated with protective immunity in humans. Mol Biochem Parasitol 1997;84:155-165.
164. 164. Lok JB, Abraham D, Animal models for the study of immunity in human filariasis. Parasitol Today 1992;8:168-171.
165. 165. Lucius R, Textor G, Kern A, Kirsten C. Acanthocheilonema viteae: vaccination of jirds with irradiation-attenuated stage-3 larvae and with exported larval antigens. Exp Parasitol 1991;73:184-196.
166. 166. Eisenbeiss WF, Apfel H, Meyer TF. Protective immunity linked with a distinct developmental stage of a filarial parasite. J Immunol 1994;152:735-742.
167. 167. Adam R, Kaltmann B, Rudin W, Friedrich T, Marti T, Lucius R. Identification of chitinase as the immunodominant filarial antigen recognized by sera of vaccinated rodents. J Biol Chem 1996;271:1441-1447.
168. 168. Hartmann S, Adam R, Marti T, Kirsten C, Seidinger S, Lucius R. A 41 -kDa antigen of the rodent filaria Acanthocheilonema viteae with homologies to tropomyosin induces host protective immune responses. Parasitol Res 1997;83:390-393.
169. 169. Li B-W, Chandrashekar R, Alvarez RM, Liftis F, Weil GJ. Identification of paramyosin as a potential protective antigen against Brugia malayi infection in jirds. Mol Biochem Parasitol 1991;49:315-324.
170. 170. Li B-W, Chandrashekar R, Weil GJ. Vaccination with recombinant filarial paramyosin induces partial immunity to Brugia malayi infection in jirds. J Immunol 1993;150:1881-1885.
171. 171. Gregory WF, Blaxter ML, Maizels RM. Differentially expressed, abundant trans-spliced cDNAs from larval Brugia malayi. Mol Biochem Parasitol 1997;87:85-95.
172. 172. Joseph GT, Huima T, Lustigman S. Characterization of an Onchocerca volvulus L3-specific larval antigen, Ov-ALT-1. Mol Biochem Parasitol 1998;96:177-183.
173. 173. Fuhrman JA. Filarial chitinases. Parasitol Today 1995;11:259-261.
174. 174. Wang SH, et al. Evaluation of recombinant chitinase and SXP1 antigens as antimicrofilarial vaccines. Am J Trop Med Hyg 1997;56:474-181.
175. 175. Taylor MJ, Jenkins RE, Bianco AE. Protective immunity induced by vaccination with Onchocerca volvulus tropomyosin in rodents. Parasite Immunol 1996;18:219-225.
176. 176. Jenkins RE, Taylor MJ, Gilvary NJ, Bianco AE. Tropomyosin implicated in host protective responses to microfilariae in onchocerciasis. Proc Natl Acad Sci USA 1998;95:7550-7555.
177. 177. Newton SE, Munn EA. The development of vaccines against gastrointestinal nematode parasites, particularly Haemonchus contortus. Parasitol Today 1999;15:116-122.
178. 178. Tavernor AS, Smith TS, Langford CF, Munn EA, Graham M. Vaccination of young Dorset lambs against haemonchosis. Parasite Immunol 1992;14:645-655.
179. 179. Strauss EJ, Falkow S. Microbial pathogenesis: genomics and beyond. Science 1997;276:707-712.
180. 180. The Filarial Genome Project. Deep within the filarial genome: in update on progress in the Filarial Genome Project. Parasitol Today (In press).
181. 181. Johnston DA, Blaxter ML, Degrave WM, Foster J, Ivens AC, Melvill SE. Genomics and the biology of parasites. Bioessays 1999;21:131-147.
182. 182. Fan J, Minchella DJ, Day SR, McManus DP, Tiu WU, Brindley PJ. Generation, identification, and evaluation of expressed sequence tags from different developmental stages of the Asian blood fluke Schistosoma japonicum. Biochem Biophys Res Commun 1998;252:348-356.
183. 183. Hoffman SL, Rogers WO, Carucci DJ, Venter JC. From genomics to vaccines: malaria as a model system. Nat Med 1998;4:1351-1353.
184. 184. Barry MA, Lai WC, Johnston SA. Protection against mycoplasma infection using expression-library immunization. Nature 1995;377:632-635.
185. 185. Mielcarek N, Riveau G, Remoué F, Antoine R, Capron A, Locht C. Homologous and heterologous protection after single intranasal administration of live attenuated recombinant Bordetella pertussis. Nat Biotech 1998;16:454-457.
186. 186. Chabalgoity JA, et al. Expression and immunogenicity of an Echinococcus granulosus fatty acid binding protein in live attenuated Salmonella vaccine strains. Infect Immun 1997;65:2402-2412.
187. 187. Chacón MR, Londono P, Dougan G, Selkirk ME. Heterologous expression of the cuticular glutathione peroxidase of lymphatic filariae in an attenuated vaccine strain of Salmonella typhimurium abrogates H-2 restriction of specific antibody responses. Parasite Immunol 1996;18:307-316.
188. 188. Roman M, et al. Immunostimulatory DNA sequences function as T helper-1-promoting adjuvants. Nat Med 1997;3:849-854.
189. 189. Donnelly JJ, Ulmer JB, Shiver JW, Liu MA. DNA vaccines. Annu Rev Immunol 1997;15:617-648.
190. 190. Rosas G, et al. Taenia crassiceps cysticercosis: humoral immune response and protection elicited by DNA immunization. J Parasitol 1998;84:516-523.
191. 191. Mountford AP, Anderson S, Wilson RA. Induction of Th1 cell-mediated protective immunity to Schistosoma mansoni by co-administration of larval antigens and IL-12 as an adjuvant. J Immunol 1996;156:4739-4745.
192. 192. Kim JJ, et al. Engineering of in vivo immune responses to DNA immunization via codelivery of costimulatory molecule genes. Nat Biotech 1997;15:641-646.
193. 193. Oehnen S. Hengartner H, Zinkernagel RM. Vaccination for disease. Science 1991;251:195-198.
194. 194. Wynn TA, et al. An IL-12-based vaccination method for preventing fibrosis induced by schistosome infection. Nature 1995;376:594-596.
195. 195. Sher A, Jankovic D, Cheever A, Wynn T. An IL-12-based vaccine approach for preventing immunopathology in schistosomiasis. Ann N Y Acad Sci 1996;795:202-207.
196. 196. Nestle FO, et al. Vaccination of melanoma patients with peptide-or tumour lysate-pulsed dendritic cells. Nat Med 1998;4:328-332.
197. 197. Stumbles PA, et al. Resting respiratory tract dendritic cells preferentially stimulate T helper cell type 2 (Th2) responses and require obligatory cytokine signals for induction of Th1 immunity. J Exp Med 1998;188:2019-2031.
198. 198. Toellner KM, et al. T helper 1 (Th1) and Th2 characteristics start to develop during T cell priming and are associated with an immediate ability to induce immunoglobulin class switching. J Exp Med 1998;187:1193-1204.
199. 199. Rissoan MC, et al. Reciprocal control of T helper cell and dendritic cell differentiation. Science 1999;283:1183-1186.
200. 200. Boyle JS, Brady JL, Lew AM. Enhanced responses to a DNA vaccine encoding a fusion antigen that is directed to sites of immune induction. Nature 1998;392:408-411.
201. 201. Johnson KS, et al. Vaccination against ovine cysticercosis using a defined recombinant antigen. Nature 1989;338:585-587.
202. 202. Shastri N. Needles in haystacks: identifying specific peptide antigens for T cells. Curr Opin Immunol 1996;8:271-277.
203. 203. Campos-Neto A, et al. Cloning and expression of a Leishmania donovani gene instructed by a peptide isolated from major histocompatibility complex class II molecules of infected macrophages. J Exp Med 1995;182:1423-1433.
204. 204. Mougneau E, et al. Expression cloning of a protective Leishmania antigen. Science 1995;268:563-566.
205. 205. Aguinaldo AMA, et al. Evidence for a clade of nematodes, arthropods and other moulting animals. Nature 1997;387:489-493.
206. 206. Conway Morris S. The fossil record and the early evolution of the Metazoa. Nature 1993;361:219-225.
207. 207. Gottstein B, et al. Specific cellular and humoral immune responses in patients with different long-term courses of alveolar eclunococcosis (infection with Echinococcus multilocularis). Am J Trop Med Hyg 1991;45:734-742.
208. 208. Nelson FK, Greiner DL, Schultz LD, Rajan TV. The immunodeficient scid mouse as a model for human lymphatic filariasis. J Exp Med 1991;173:659-663.
209. + T-lymphocytes are not required for murine resistance to the human filarial parasite, Brugia malayi. Exp Parasitol 1994;78:352-360.
210. 210. Ovington KS, Behm CA. The enigmatic eosinophil: investigation of the biological role of eosinophils in parasitic helminth infection. Mem Inst Oswaldo Cruz 1997;92 (Suppl 2):93-104.
211. 211. Lawrence RA, Gray C, Osborne J, Maizels RM. Nippostrongylus brasiliensis: cytokine responses and nematode expulsion in normal and IL4-deficient mice. Exp Parasitol 1996;84:65-73.
212. 212. Ferru I, Roye O, Delacre M, Auriault C, Wolowczuk I. Infection of B-cell deficient mice by the parasite Schistosoma mansoni: demonstration of the participation of B cells in granuloma modulation. Scand J Immunol 1998;48:233-240.
213. 213. Jankovic D, et al. Optimal vaccination against Schistosoma mansoni requires the induction of both B cell-and IFN-γ-dependent effector mechanisms. J Immunol 1999;162:345-351.
214. 214. Rotman HL, et al. Strongyloides stercoralis: complete life cycle in SCID mice. Exp Parasitol 1995;81:136-139.
215. 215. Ovington KS, McKie K, Matthaei KI, Yonng IG, Behm CA. Regulation of primary Strongyloides ratti infections in mice: a role for interleukin-5. Immunology 1998;95:488-493.
216. 216. Else K, Grencis RK. Antibody-independent effector mechanisms in resistance to the intestinal nematode parasite Trichuris muris. Infect Immun 1996;64:2950-2954.
217. 217. Chenthamarakshan V, Reddy MVR, Harinath BC. Immunoprophylactic potential of a 120 kDa Brugia malayi adult antigen fraction, BmA-2, in lymphatic filariasis. Parasite Immunol 1995;17:277-285.
218. 218. Nanduri J, Kazura JW. Paramyosin-enhanced clearance of Brugia malayi microfilaremia in mice. J Immunol 1989;143:3359-3363.
219. 219. Sexton JL, et al. Glutathione S transferase. Novel vaccine against Fasciola hepatica infection in sheep. J Immunol 1990;145:3905-3910.
220. 220. Dalton JP, McGonigle S, Roplh TP, Andrews SJ. Induction of protective immunity in cattle against infection with Fasciola hepatica by vaccination with cathepsin L proteinases and with hemoglobin. Infect Immun 1996;64:5066-5074.
221. 221. Jasmer DP, Perryman LE, Conder GA, Crow S, McGuire T. Protective immunity to Haemonchus contortus induced by immunoaffinity isolated antigens that share a phylogenetically conserved carbohydrate gut surface epitope. J Immunol 1993;151:5450-5460.
222. 222. Balloul JM, Grzych JM, Pierce RJ, Capron A. A purified 28,000 dalton protein from Schistosoma mansoni adult worms protects rats and mice against experimental schistosomiasis. J Immunol 1987;138:3448-3453.
223. 223. Pearce EJ, James SL, Hieny S, Lanar DE, Sher A. Induction of protective immunity against Schistosoma mansoni by vaccination with schistosome paramyosin (Sm97), a nonsurface parasite antigen. Proc Natl Acad Sci USA 1988;85:5678-5682.
224. 224. Silberstein DS, Despommier DD. Antigens from Trichinella spiralis that induce a protective response in the mouse. J Immunol 1984;132:898-904.
225. 225. Frenkel MJ, Dopheide TAA, Wagland BM, Ward CW. The isolation, characterization and cloning of a globin-like, host-protective antigen from the excretory-secretory products of Trichostrongylus colubriformis. Mol Biochem Parasitol 1992;50:27-36.
226. 226. Harn DA, Gu W, Oligino LD, Mitsuyama M, Gebremichael A, Richter D. A protective monoclonal-antibody specifically recognizes and alters the catalytic activity of schistosome triose-phosphate isomerase. J Immunol 1992;148:562-567.
227. 227. Lightowlers MW, et al. Vaccination against hydatidosis using a defined recombinant antigen. Parasite Immunol 1996;18:457-462.
228. 228. Manoutcharian K, et al. Cysticercosis: identification and cloning of protective recombinant antigens. J Parasitol 1996;82:250-254.
229. 229. Lightowlers MW, Rolfe R, Gauci CG. Taenia saginata: vaccination against cysticercosis in cattle with recombinant onosphere. antigens. Exp Parasitol 1996;84:330-338.
230. 230. Ghosh K, Hawdon J, Hotez P. Vaccination with alum-precipitated recombinant Ancylostoma-secreted protein 1 protects mice against challenge infections with infective hookworm (Ancylostoma caninum) larvae. J Infect Dis 1996;174:1380-1383.
231. 231. Robinson K, Bellaby T, Chan WC, Wakelin D. High levels of protection induced by a 40-mer synthetic peptide vaccine against the intestinal nematode parasite Trichinella spiralis. Immunology 1995;86:495-498.
232. 232. Balloul JM, et al. Molecular cloning of a protective antigen of schistosomes. Nature 1987;326:149-153.
233. 233. Rothel JS, et al. Sequential nucleic acid and recombinant adenovirus vaccination induces host-protective immune responses against Taenia ovis infection in sheep. Parasite Immunol 1997;19:221-227.
234. 234. Yang W, Waine GJ, McManus DP. Antibodies to Schistosoma japonicum (Asian bloodfluke) paramyosin induced by nucleic acid vaccination. Biochem Biophys Res Commun 1995;212:1029-1039.
235. 235. Waine GJ, Mazzer DR, McManus DP. DNA immunization by intramuscular injection or gene gun induces specific IgG antibodies against a Schistosoma japonicum 22 kDa antigen. Sj22, when fused to the murine Ig K-chain secretory leader sequence. Parasite Immunol 1999;21:53-56.
236. 236. Kayes SG, Shaneyfelt RC, Monteiro C, O'Brien JJ. Overproduction of SM28GST in a baculovirus expression vector and its use to evaluate the in vivo immune responses of mice vaccinated against Schistosoma mansoni with naked DNA encoding the SM28GST gene. J Parasitol 1998;84:764-770.